These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 12054129)
1. Effect of growth hormone on growth failure and bone loss induced by supraphysiologic dose of glucocorticoid in rats. Sato M; Dobashi H; Ohye H; Akiyama T; Kawanishi J; Kaji Y; Mori S; Takahara J Endocr J; 1999 Mar; 46 Suppl():S89-92. PubMed ID: 12054129 [No Abstract] [Full Text] [Related]
2. Growth hormone increases the CD4/CD8 ratio in splenic lymphocytes in glucocorticoid-treated rats. Dobashi H; Sato M; Tanaka T; Mitsunaka H; Yamaoka G; Tokuda M; Takahara J Endocr J; 2000 Mar; 47 Suppl():S29-32. PubMed ID: 10890178 [No Abstract] [Full Text] [Related]
3. Growth hormone administration can improve growth in glucocorticoid-injected rats without affecting the lymphocytopenic effect of the glucocorticoid. Ortoft G; Grønbaek H; Oxlund H Growth Horm IGF Res; 1998 Jun; 8(3):251-64. PubMed ID: 10984314 [TBL] [Abstract][Full Text] [Related]
4. Effect of growth hormone in an experimental model of protein hypercatabolism induced by glucocorticoids. Cantón A; Trainer PJ; Martinez-Cáceres E; Simó R Horm Metab Res; 2006 Sep; 38(9):556-62. PubMed ID: 16981136 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone stimulates bone formation and strength of cortical bone in aged rats. Andreassen TT; Jørgensen PH; Flyvbjerg A; Orskov H; Oxlund H J Bone Miner Res; 1995 Jul; 10(7):1057-67. PubMed ID: 7484281 [TBL] [Abstract][Full Text] [Related]
6. The response of the hepatic insulin-like growth factor system to growth hormone and dexamethasone in calves. Hammon HM; Zbinden Y; Sauerwein H; Breier BH; Blum JW; Donkin SS J Endocrinol; 2003 Dec; 179(3):427-35. PubMed ID: 14656212 [TBL] [Abstract][Full Text] [Related]
7. Effects of short- and long-term dexamethasone treatment on growth and growth hormone (GH)-releasing hormone (GRH)-GH-insulin-like growth factor-I axis in conscious rats. Ohyama T; Sato M; Niimi M; Hizuka N; Takahara J Endocr J; 1997 Dec; 44(6):827-35. PubMed ID: 9622298 [TBL] [Abstract][Full Text] [Related]
8. Diverse effects of glucocorticoids on the hypothalamic pituitary axis in rat growth hormone secretion. Ohyama T; Sato M; Wada Y; Takahara J Endocr J; 1996 Oct; 43 Suppl():S115-7. PubMed ID: 9076357 [No Abstract] [Full Text] [Related]
9. Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect. Ortoft G; Brüel A; Andreassen TT; Oxlund H Bone; 1995 Dec; 17(6):543-48. PubMed ID: 8835308 [TBL] [Abstract][Full Text] [Related]
10. The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. Tulipano G; Rossi E; Culler MD; Taylor JE; Bonadonna S; Locatelli V; Cocchi D; Giustina A Regul Pept; 2005 Feb; 125(1-3):85-92. PubMed ID: 15582718 [TBL] [Abstract][Full Text] [Related]
11. [Growth as an oscillatory phenomenon]. Fernández-Tresguerres JA An R Acad Nac Med (Madr); 1994; 111(4):697-706; discussion 707. PubMed ID: 7598207 [No Abstract] [Full Text] [Related]
12. Growth hormone and insulin-like growth factor-I therapy promote protein deposition and growth in dexamethasone-treated piglets. Ward WE; Atkinson SA J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):404-10. PubMed ID: 10204505 [TBL] [Abstract][Full Text] [Related]
14. Histologic evidence: growth hormone completely prevents reduction in cortical bone gain and partially prevents cancellous osteopenia in the tibia of hypophysectomized rats. Chen MM; Yeh JK; Aloia JF Anat Rec; 1997 Oct; 249(2):163-72. PubMed ID: 9335461 [TBL] [Abstract][Full Text] [Related]
15. Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth factor-I (IGF-I) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes. Beauloye V; Ketelslegers JM; Moreau B; Thissen JP Growth Horm IGF Res; 1999 Jun; 9(3):205-11. PubMed ID: 10502457 [TBL] [Abstract][Full Text] [Related]
16. The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects. Scutt A; Bertram P; Bräutigam M Calcif Tissue Int; 1996 Sep; 59(3):154-62. PubMed ID: 8694891 [TBL] [Abstract][Full Text] [Related]
17. Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats. Priego T; Granado M; Martín AI; López-Calderón A; Villanúa MA J Endocrinol; 2005 Jun; 185(3):467-76. PubMed ID: 15930173 [TBL] [Abstract][Full Text] [Related]
18. Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo. Wehrenberg WB; Baird A; Ling N Science; 1983 Aug; 221(4610):556-8. PubMed ID: 6408735 [TBL] [Abstract][Full Text] [Related]
19. Morphological changes of the cartilage and bone in newborn piglets evoked by experimentally induced glucocorticoid excess during pregnancy. Tomaszewska E; Dobrowolski P; Puzio I J Anim Physiol Anim Nutr (Berl); 2013 Aug; 97(4):785-96. PubMed ID: 22716040 [TBL] [Abstract][Full Text] [Related]
20. Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose. Dobrowolski P; Tomaszewska E; Muszyński S; Blicharski T; Pierzynowski SG Exp Biol Med (Maywood); 2017 Apr; 242(7):671-682. PubMed ID: 28178857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]